The ATXN1 gene helps brain cells control the activity of other genes and supports the nerve pathways used for balance and coordination. This gene plays an important role in keeping certain cells in the cerebellum, the part of the brain that helps manage movement, healthy. A harmful repeat expansion in the ATXN1 gene can damage these cells and cause spinocerebellar ataxia type 1, which often leads to trouble with walking, speech, swallowing, and fine hand movements. It usually runs in families.
What is a gene?
Within DNA, a gene is a segment that holds instructions cells use to make molecules or direct processes in the body. Some genes provide the information needed to make proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes occur, where they occur, and how strongly they run. In combination, genes influence how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To explore this subject in more detail, see the LearnHub.
Overview
ATXN1Gene function
What if the gene works
The ATXN1 gene helps brain cells control which other genes are turned on or off. Its protein is especially active in the cerebellum, where it supports normal nerve cell function and coordination.
Risk
What if the gene does not work
Expanded repeats in the ATXN1 gene can cause spinocerebellar ataxia type 1, with worsening balance, coordination, speech, and swallowing problems. Larger expansions often mean earlier, more severe symptoms, while some other variants are linked to developmental delay and learning difficulties.
Treatment
What does that mean for your treatment
No ATXN1-specific treatment or drug selection approach is currently established in clinical guidelines. Care is symptom based, and the ATXN1 gene is being studied as a target for gene silencing and other disease modifying therapies in spinocerebellar ataxia type 1.
Conditions associated with ATXN1
Gene function
What if the gene works
Your cells use the ATXN1 gene to help manage which instructions are read and how RNA messages are handled. Most of this work happens in the nucleus, where cells organize and use genetic information. Understanding how the ATXN1 gene supports nerve cell function helps explain its role in steady everyday cell activity.
The ATXN1 gene helps cells control which other genes are switched on or kept quieter. Its protein joins groups in the nucleus that fine tune when cell instructions are used.
ATXN1 also helps manage RNA, the working copy of genetic instructions used to make proteins. It interacts with proteins that shape and edit these messages before cells use them.
Inside the nucleus, ATXN1 acts as part of larger protein teams rather than working alone. This helps cells coordinate gene activity with RNA processing in a more organized way.
What is a variant?
Genetic variants are small differences in the DNA sequence within a gene. They are common and help create normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In the ATXN1 gene, the best known variant is a CAG repeat expansion, and this explains how ATXN1 gene variants affect protein function. The extra repeats create an abnormally long protein segment that can misfold, collect in the cell nucleus, and interfere with other proteins in nerve cells. Shorter expansions may disturb the protein less, while larger expansions often have stronger effects and are linked to earlier and more marked spinocerebellar ataxia type 1.
How variants are linked to conditions
A pathogenic expanded CAG repeat in the ATXN1 gene causes spinocerebellar ataxia type 1, often called SCA1. In practical terms, ATXN1 gene variants linked to spinocerebellar ataxia type 1 can lead to gradually worsening problems with balance, coordination, speech, and swallowing. This is a well-established inherited condition, and finding the pathogenic repeat expansion can confirm the diagnosis. Even within the same family, the age symptoms begin and how they progress can vary.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology across the general population. Most do not directly affect health and instead reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link, not a definite diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATXN1, risk is driven mainly by inheriting a disease-causing repeat expansion, so day-to-day habits are not known to prevent the condition. Longer repeat sizes can be linked to earlier symptoms, and avoiding falls, excess alcohol, or medicines that worsen balance may help limit complications once symptoms begin.
Inheritance of ATXN1 variants
Variants in the ATXN1 gene linked to spinocerebellar ataxia type 1 are inherited in an autosomal dominant pattern. This means a person who carries a disease causing ATXN1 gene variant has a 50% chance of passing it to each child, whether the child is a son or daughter. In families, the ATXN1 inheritance pattern often appears across generations. A child who does not inherit the variant will not pass it on to their own children.
What does my ATXN1 result mean for my family?
A disease-causing change in the ATXN1 gene is usually passed down in families in a dominant pattern, so close relatives may also carry the same change. This often means each child of an affected parent has a 1 in 2, or 50%, chance of inheriting it. Brothers, sisters, and parents may also want to learn whether the change is present in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the ATXN1 gene, doctors use genetic testing for ATXN1 variants on a blood or saliva sample. A lab reads the gene’s DNA code to look for changes and compares them with known patterns to decide whether a variant is linked to disease, likely harmless, or still unclear.
When should I consider getting a genetic test?
Consider ATXN1 testing if you or a close relative has a slowly worsening balance or coordination problem, slurred speech, or trouble swallowing, especially when it runs in the family. Testing is also often considered when a family member has been diagnosed with spinocerebellar ataxia type 1, so relatives can learn whether they carry the same gene change.
A genetic result is only one part of your health story
Genetic findings can provide valuable insight, but how much they reveal varies by the condition and the specific type of variant. Factors such as age, lifestyle, environment, and medical history also influence how the body functions over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment at the same dose, yet one may get the intended benefit while another may notice less effect or be more sensitive to side effects. This happens in part because inherited differences can change how the body breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic variation can affect how a person responds to medicines. By studying links between genes and medications, it helps explain why the same treatment may work differently in different people. With many drugs, genes can influence both how powerfully a medicine works and how the body handles it. This information can support treatment decisions that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the ATXN1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about medicines, side effects, or changes in your health are best discussed with your doctor or pharmacist.
History
Families and communities once noticed patterns that seemed to pass from parent to child. In the 19th century, doctors described inherited forms of progressive balance and coordination problems that were later recognized as spinocerebellar ataxia. Building on this early work, scientists mapped spinocerebellar ataxia type 1 to chromosome 6 in the late 1980s. In 1993, researchers identified the ATXN1 gene and showed that an expanded CAG repeat was the cause in affected families. That discovery helped confirm a broader group of repeat expansion conditions and changed how neurologists classified inherited ataxias. From these first observations, research expanded steadily, making the ATXN1 gene an important part of modern neurogenetics.